• The-year-of-more.png
  • Go

    Pages

      Members

        Categories

          Quicklinks

            Events

            • Speaking of Your Health-New Radiation Option for Prostate Cancer Cuts the Treatment Time in Half

              • Share:
              November 09, 2020
              New Radiation Option for Prostate Cancer Cuts the Treatment Time in Half
               
              Prostate cancer is the most common cancer diagnosed in men in the nation. Nearly 191,930 new cases will be detected in the United States in 2020, according to the American Cancer Society. Prostate cancer is also the third leading cause of cancer deaths in men behind lung cancer and colorectal cancer. Fortunately, prostate cancer mortality rates have been decreasing since the mid-1990s in both African American and Caucasian men. This decrease is often attributed to our improved ability to detect and then treat the disease in its early stages.
               
              Treatment for prostate cancer often involves surgery (a radical prostatectomy to remove the prostate) or radiation therapy.
               
              As Radiation Oncologists, we treat prostate cancer using IMRT or intensity modulated radiotherapy, a special form of external-beam radiation therapy. With IMRT, we are able to precisely deliver the dose of radiation directly to the prostate, minimizing harm to the surrounding organs including the bladder, the rectum, the femoral heads and the small bowel. In addition, IMRT has been shown to be beneficial in reducing long-term side effects of prostate cancer.
               
              Advancements in technology, treatment planning and imaging has also led to new innovations in radiation treatment such as hypofractionated radiation therapy for localized prostate cancer which we now offer at the McLeod Center for Cancer Treatment and Research.
               
              Click Here to Read More.
              Dr. Larry D. Grubb has been caring for patients at the
              McLeod Center for Cancer Treatment and Research since 1992. 
               
               
               
              Contact:
              Tracie Foster
              tfoster@mcleodhealth.org, (843) 777-5493